NCT05461794 2025-06-13Study To Investigate the Efficacy and Safety of Sitravatinib in Combination With Tislelizumab in Participants With Esophageal Squamous Cell CarcinomaBeiGenePhase 2 Terminated96 enrolled 17 charts